1.Langenberg C，Wan L，Egi M，et al.Renal blood flow in experimental septic acute renal failure.Kidney Int，2006，69：1996-2002.

2.Rajendram R，Prowle JR.Venous congestion：arewe adding insult to kidney injury in sepsis.CritCare，2014，18：104.

3.Boyd JH，Forbes J，Nakada TA，et al.Fluid resuscitation in septic shock：a positive fluid balance and elevated central venous pressure are associated with increased mortality.Crit Care Med，2011，39：259-265.

4.陈秀凯，李素玮，刘大为，等.中心静脉压在感染性休克所致急性肾损伤中的作用.中华医学杂志，2011，91（19）：1323-1327.

5.陈秀凯，李文雄.腹腔高压并发急性肾损伤：压力重于容量.中华医学杂志，2012，92（15）：1009-1011.

6.Schnell D，Reynaud M，VenotM，etal.Resistive Index or color-Doppler semi-quantitative evaluation of renal perfusion by inexperienced physicians：results of a pilot study.Minerva Anestesiol，2014，80：1273-1281.

7.Schnell D，Camous L，Guyomarc'h S，et al.Renal perfusion assessmentby renal Doppler during fluid challenge in sepsis.Crit Care Med，2013，41：1214-1220.

8.Clevert DA，D'Anastasi M，Jung EM.Contrast-enhanced ultrasound and microcirculation：efficiency through dynamics-current developments.Clin Hemorheol Microcirc，2013，53：171-186.

9.Meola M，Petrucci I.Ultrasound and color Doppler in nephrology.Acute kidney injury.G Ital Nefrol，2012，29：599-615.

10.Bellomo R，Kellum JA，Bagshaw SM.Normotensive ischemic acute renal failure.N Engl J Med，2007，357：2205.

11.Labib M，Khalid R，Khan A，et al.Volume management in the critically ill patientwith acute kidney injury.Crit Care Res Pract，2013，2013：792-830.

12.Prowle JR，Leitch A，Kirwan CJ，et al.Positive fluid balance and AKI diagnosis：assessing the extent and duration of creatinine dilution.Intensive Care Med，2015，41：160-161.

13.de Witt B，Joshi R，Meislin H，et al.Optimizing oxygen delivery in the critically ill：assessment of volume responsiveness in the septic patient.JEmerg Med，2014，47：608-615.

14.Chawla LS，Kellum JA，Ronco C.Permissive hypofiltration.Crit Care，2012，16：317.

15.Al-Hesayen A，Parker JD.The effects of dobutamine on renal sympathetic activity in human heart failure.JCardiovasc Pharmacol，2008，51：434-436.

16.Day NP，Phu NH，Mai NT，et al.Effects of dopamine and epinephrine infusions on renal hemodynamics in severe malaria and severe sepsis.Crit Care Med，2000，28：1353-1362.

17.Yealy DM，Kellum JA，Huang DT，etal.A randomized trial of protocol-based care for early septic shock.N Engl JMed，2014，370：1683-1693.

18.Rivers E，Nguyen B，Havstad S，et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock.N Engl JMed，2001，345：1368-1377.

19.Nadeem A，Salahuddin N，ElHazmi A，et al.Chloride-liberal fluids are associated with acute kidney injury after liver transplantation.Crit Care，2014，18：625.

20.Moussa MD，Scolletta S，Fagnoul D，et al.Effects of fluid administration on renal perfusion in critically ill patients.Crit Care，2015，19：250.

21.Asfar P，Meziani F，Hamel JF，etal.High versus low blood-pressure target in patientswith septic shock.N Engl JMed，2014，370：1583-1593.

22.Deruddre S，Cheisson G，Mazoit JX，et al.Renal arterial resistance in septic shock：effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography.Intensive Care Med，2007，33：1557-1562.

23.Gordon AC，Russell JA，Walley KR，et al.The effects of vasopressin on acute kidney injury in septic shock.Intensive Care Med，2010，36：83-91.

24.Sanyal AJ，Boyer T，Garcia-Tsao G，et al.A randomized，prospective，double-blind，placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.Gastroenterology，2008，134：1360-1368.

25.Morelli S RZR，Ronco C，Picardo S.Prophylactic fenoldopam for renal protection in sepsis.Crit Care Med，2005，33：2451-2456.

26.Kellum JA，Lameire N.Diagnosis，evaluation，and management of acute kidney injury：a KDIGO summary（Part 1）.Crit Care，2013，17：204-219.

27.Nigwekar SU，Navaneethan SD，Parikh CR，et al.Atrial natriuretic peptide for managementof acute kidney injury：a systematic review and meta-analysis.Clin JAm Soc Nephrol，2009，4：261-272.

28.Martenssona J，Bellomo R.Pathophysiology of septic acute kidney injury.Contrib Nephrol，2016，187：36-46.

29.Prowle JR，Bellomo R.Fluid administration and the kidney.Curr Opin Crit Care，2013，19：308-314.

30.Aksu U，Bezemer R，DemirciC，et al.Acute effects of balanced versus unbalanced colloid resuscitation on renal macrocirculatory and microcirculatory perfusion during endotoxemic.Shock，2012，37：205-209.

31.Yunos NM，Bellomo R，Hegarty C，et al.Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults.JAMA，2012，308：1566-1572.

32.Gaironi P，Tognoni G，Masson S，et al.Albumin replacement in patients with severe sepsis or septic shock.N Engl JMed，2014，370：1412-1421.

33.Finfer S，Bellomo R，Boyce N，et al.A comparison of albumin and saline for resuscitation in the intensive care unit.N Engl JMed，2004，350：2247-2256.

34.Perner A，Haase N，Guttormsen AB，et al.Hydroxyethyl starch 130/0.4 versus Ringer’s acetate in severe sepsis.N Engl JMed，2012，367：124-134.

35.马朋林.羟乙基淀粉在脓毒症液体复苏中应用与争议.中国实用外科杂志，2013，35：148-151.

36.Young P，Bailey M，Beasley R，et al.Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit：the SPLIT randomized clinical trial.JAMA，2015，314：1701-1710.

37.Soussi S，Ferry A，Chaussard M，et al.Chloride toxicity in critically ill patients：What’s the evidence？Anaesth Crit Care Pain Med，2017，36：125-130.

38.Hu SL，Said FR，Epstein D，et al.The impact of anemia on renal recovery and survival in acute kidney injury.Clin Nephrol，2013，79：221-228.

39.SpasovskiG，Vanholder R，Allolio B，etal.Clinical practice guideline on diagnosis and treatmentof hyponatraemia.Nephrol Dial Transplant，2014，29 Suppl 2：i1-i39.

40.Taylor BE，McClave SA，Martindale RG，et al.Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient：Society of Critical Care Medicine（SCCM）and American Society for Parenteral and Enteral Nutrition（A.S.P.E.N.）.J Parenter Enteral Nutr，2016，40：159-211.

41.Wiesen P，Overmeire LV，Delanaye P，et al.Nutrition disorders during acute renal failure and renal replacement therapy.JParenter Enteral Nutr，2011，35：217-222.

42.Heyland D，Muscedere J，Wischmeyer PE，etal.A randomized trialof glutamine and antioxidants in critically ill patients.N Engl JMed，2013，368：1889-1897.

43.Iglesias P，Selgas R，Romero S，et al.Selenium and kidney disease.JNephrol，2013，26：266-272.

44.Wiesen P，Van Overmeire L.Nutrition disorders during acute renal failure and renal replacement therapy.JParenter Enteral Nutr，2010，35：217-222.

45.李文雄.急性肾损伤患者的营养支持.中国急救医学，2013，33（7）：614-617.

46.Doig GS，Simpson F，Bellomo R，et al.Intravenous amino acid therapy for kidney function in critically ill patients：a randomized controlled trial.Intensive Care Med，2015，41：1197-1208.

47.Gunst J，Van den Berghe G.Parenteral nutrition in the critically ill.Curr Opin Crit Care，2017，23：149-158.

48.Datzmann T，Träger K，Reinelt H，et al.Elimination rates of electrolytes，vitamins，and trace elements during continuous renal replacement therapy with citrate continuous veno-venous hemodialysis：influence of filter lifetime.Blood Purif，2017，44：210-216.

49.Bellomo R，Ronco C，Kellum JA，et al.Acute Dialysis Quality Initiative workgroup.Acute renal failure-definition，outcome measures，animal models，fluid therapy and information technology needs：the Second International Consensus Conference of the Acute Dialysis Quality Initiative（ADQI）Group.Crit Care，2004，8：R204-R212.

50.Sampath S，Moran JL，Graham PL，et al.The efficacy of loop diuretics in acute renal failure：assessment using Bayesian evidence synthesis techniques.Crit Care Med，2007，35：2516-2524.

51.Ho KM，Power BM.Benefits and risks of furosemide in acute kidney injury.Anaesthesia，2010，65：283-293.

52.Bellomo R，Kellum JA，Ronco C.Acute kidney injury.Lancet，2012，80：756-766.

53.Bellomo R，Chapman M，Finfer S，et al.Low-dose dopamine in patientswith early renal dysfunction：a placebocontrolled randomised trial.Australian and New Zealand Intensive Care Society（ANZICS）Clinical Trials Group.Lancet，2000，356：2139-2143.

54.Sward K，Valsson F，Odencrants P，et al.Recombinant human atrial natriuretic peptide in ischemic acute renal failure：a randomized placebo-controlled trial.Crit Care Med，2004，32：1310-1315.

55.Biancofiore G，Bindi ML，MiccoliM，et al.Intravenous fenoldopam for early acute kidney injury after liver transplantation.JAnesth，2015，29：426-432.

56.Endre ZH，Walker RJ，Pickering JW，et al.Early intervention with erythropoietin does not affect the outcome of acute kidney injury（the EARLYARF trial）.Kidney Int，2010，77：1020-1030.